Araraquara, Brazil

Man Chin Chung

This inventor holds 1 USPTO granted patent. Top assignee: Ems S.a.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Man Chin Chung. Retrieved from https://idiyas.com/inventor/man-chin-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Man Chin Chung: Innovator in Antibacterial Compounds

Introduction

Man Chin Chung is a notable inventor based in Araraquara, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial and antiprotozoal compounds. His work focuses on creating effective solutions for combating infections and improving health outcomes.

Latest Patents

Man Chin Chung holds a patent for "Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity." This patent describes nitroimidazolic derivative compounds that exhibit potent antibacterial and antiprotozoal activity, functioning as effective urease inhibitors. The application outlines the process for preparing these compounds and their potential use in pharmaceutical compositions and medicines. He has 1 patent to his name.

Career Highlights

Chung is associated with Ems S.A., a company known for its commitment to innovation in the pharmaceutical industry. His work at Ems S.A. has allowed him to contribute to the development of new therapeutic agents that address critical health challenges.

Collaborations

Throughout his career, Man Chin Chung has collaborated with esteemed colleagues, including Renato F Menegon and Lúcia Castro. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field.

Conclusion

Man Chin Chung's innovative work in developing antibacterial and antiprotozoal compounds highlights his dedication to improving healthcare solutions. His contributions to the pharmaceutical industry are significant and continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…